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Background: Laparoscopic liver ablation therapy can be
used for the treatment of primary and secondary liver
malignancy. The increased incidence of cancer recurrence
associated with this approach, has been attributed to the
inability of monitoring the extent of ablated liver tissue.
Methods: The feasibility of assessing liver ablation with
probe-based confocal laser endomicroscopy (CLE) was
studied in a porcine model of laparoscopic microwave liver
ablation. Following the intravenous injection of the
fluorophores fluorescein and indocyanine green, CLE
images were recorded at 488nm and 660nm wavelength
and compared to liver histology. Statistical analysis was
performed to assess if fluorescence intensity change can
predict the presence of ablated liver tissue.
Results: CLE imaging of fluorescein at 488nm provided
good visualization of the hepatic microvasculature;
whereas, CLE imaging of indocyanine green at 660nm
enabled detailed visualization of hepatic sinusoid archi-
tecture and interlobular septations. Fluorescence intensity
as measured in relative fluorescence units was found to be
75–100% lower in ablated compared to healthy liver
regions. General linear mixed modeling and ROC analysis
found the decrease in fluorescence to be statistically
significant.
Conclusion:Laparoscopic, dualwavelengthCLE imaging
using two different fluorophores enables clinically useful
visualization of multiple liver tissue compartments, in
greater detail than is possible at a single wavelength. CLE
imaging may provide valuable intraoperative information
on the extent of laparoscopic liver ablation. Lasers Surg.
Med. 48:299–310, 2016.  2015 The Authors. Lasers in
Surgery andMedicine Published byWiley Periodicals, Inc.
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INTRODUCTION
Thermal ablation is a minimal invasive therapy, which
can be used for the treatment of primary or secondary liver
malignancy [1,2]. During the procedure, an ablation probe
is inserted into the liver lesion where it causes thermal-
mediated denaturization of proteins which results in the
destruction of cancer cells. Most commonly, heat is created
by radiofrequency or microwave energy, but laser or high
intensity focused ultrasound-induced heat can also be
employed [2]. The ablation probe can be applied by
percutaneous, laparoscopic, or open approaches. The
laparoscopic approach allows easy access to tumors which
are difficult to treat percutaneously such as those
superficially in the liver or high under the diaphragm. It
also permits use of laparoscopic ultrasound to localize the
lesion and assess its relationship to local vital structures,
hence reducing the incidence of collateral injuries [3].With
small solitary liver cancers thermal ablation may produce
comparable results to liver resection with a reduced
morbidity and mortality [4]. The main concern regarding
thermal ablation is the high incidence of local recurrent
disease and the main aim of ablation therapy is, therefore,
to destroy not only the cancer harboring tissue but also a
5–10mm safety margin to include any local satellite
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lesions. Ablated liver tissue changes in color from brown to
white (total coagulation effect) but the spatial dimension of
cellular destruction and functional damage extends well
beyond this phenomenon, therefore making ablation
monitoring crucial andmandating development of a visual
inspection or detection device to locate the real damage
margins. Using ultrasound for monitoring is unreliable
because ablation therapy generates gas bubbles within the
hepatic tissue which subsequently creates an acoustic
shadow effect, negating any diagnostic value to the
images [5,6]. Conventional computer tomography (CT)
and magnetic resonance imaging (MRI) are commonly
used for the postoperative assessment of ablation effi-
cacy [7,8] only, whereas intraoperative cone beam CT and
open MRI scanners may be used but technical restrictions
such as incompatibility with metal instruments (MRI) [9]
and limited imaging quality (cone beam CT) make them
impractical for the intraoperative evaluation of ablation
therapy.
During thermal ablation, there is a significant change in
tissue temperature which in itself can be regarded as a
surrogate marker for cellular destruction [6]. This rela-
tionship has been exploited for the purpose of noninvasive
ablation monitoring, with MR- or CT thermography [9]. In
a more direct approach, tissue temperature can also be
measured invasively by placing optical fibers under image
guidance within liver tissue [5]. This approach however
confers the risk of needle tract seeding [10], that is, the risk
of displacing tumor cells with the needle, into normal
tissue and, therefore, disseminating the malignancy
unnecessarily. Measuring changes in tissue elasticity by
shear wave elastography has also been investigated for its
utility in ablation monitoring [9,11]. The modalities listed
above measure surrogate markers for tissue necrosis but a
method of directly imaging the changes in the ablation
zone has yet to be identified.
Confocal laser endomicroscopy (CLE) is a novel optical
imaging technology that enables accurate microscopic
assessment of in vivo histopathology. Its utilization in a
variety of experimental and clinical scenarios has been
increasingly reported. CLE utilizes a fiber optic element
as its objective lens, allowing confocal microscopy with a
micron-scale resolution that enables visualization of
subcellular details using endogenous or exogenous
fluorescence. Exogenous fluorescence is provided by
fluorescent dyes, which can be applied in a systemic
(e.g., intravenous) or topical fashion and are commonly
referred to as fluorophores. They enhance CLE image
contrast by absorbing and emitting light at wavelengths
that are specific for each individual agent and
circumstance [12,13].
CLE during laparoscopy or NOTES (Natural Orifice
Transluminal Endoscopic Surgery) has been performed
either with a rigid endomicroscope which contains the
scanning optics in its tip [13] or with a slim, flexible optical
fiber bundle which transmits light signals to laser
scanning equipment situated at the far (e.g., extracorpo-
real) end of the intrusive fiber [14,15]. An example for a
fiber-based CLE system is CellvizioTM (Mauna Kea
Technologies, Paris, France), which is CE-marked for
clinical use in luminal endoscopy and can be operated with
probes that have a diameter range of 0.3–4.5mm. During
endoscopy, CellvizioTM can reveal histopathological cellu-
lar changes and has been shown to enhance accuracy in the
diagnosis of malignancy and dysplasia [13,16].
Liver ablation has been visualized using a bench-top
confocal laser microscope in a small animal model [17], but
the diagnostic ability of a clinically approved CLE system
to distinguish between healthy and necrotic liver tissue in
a laparoscopic setting have yet to be tested. In this study,
we aimed to evaluate if CLE imaging employing the
CellvizioTM system’s potential can diagnose tissue necrosis
in an in vivo porcine model of laparoscopic microwave liver
ablation.
For establishment of the model, percutaneous micro-
wave ablation was conducted under direct laparoscopic
visualization. As the CLE system used in this study has a
limited imaging depth of <100mm, only superficial
ablation zones were created and assessed. Optical scatter-
ing in hepatic tissue is very high and imaging depths are
likely to be no better in any other optical technique.
Imaging of subsurface ablation zones was not attempted.
However, imaging of deeper ablated areas is of clinical
relevance, and CLE via a placed optical fiber within the
periphery of an ablation volume may be a potential
approach to achieving this.
Previous groups evaluating laparoscopic CLE have used
single fluorophores that are usually visible on CLE
imaging within the blue-light or near-infrared spec-
trum [14,18,19]. For the experiments presented here,
dualwavelengthCLE imaging at 488nm (blue) and660nm
(red) wavelength was facilitated by the fluorophores
fluorescein and indocyanine green (ICG). By evaluating
liver tissue at two discreet wavelengths and dissimilarly
partitioned fluorophores, we aimed to maximize imaging
information and highlight any potential advantages or
disadvantages between the wavelengths and their corre-
sponding fluorophores. The image acquisition software
(ImageCellTM) supplied with CellvizioTM can compute
basic image values (mean, median, maximum, minimum
intensities). As well as comparing images, basic image
summary statistics have been analyzed to establish if they
can aid in defining the zone of tissue necrosis associated
with microwave ablation.
This article makes the following contributions:
(1) Description of normal porcine liver histology on CLE
examination using fluorescein at 488nm and indoc-
yanine green at 660nm illumination.
(2) Evaluate the technical feasibility and limitations of
CLE in an intraoperative setting.
(3) Assess the ability of CLE to predict liver tissue necrosis
induced by ablation therapy.
METHODS
The experiments outlined below were performed in
parallel with a different study conducted on the same
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animal, which has already been reported elsewhere [20]. In
brief; stereoscopic liver surface reconstruction and optical
tracking were used to develop an image guidance system
for laparoscopic liver surgery.
Sequence of Events
The experimental flow model is listed below,
sequentially:
(1) Laparoscopic microwave ablation.
(2) Recovery period of 7–10 days.
(3) Laparoscopic CLE image acquisition (following lapa-
roscopic liver resection in two cases).
(4) Post mortem liver biopsies.
Study Animals
Following approval by the local animal ethics committee,
experiments were performed at Northwick Park Institute
for Medical Research (London). A total of four female
landrace mini-pigs with a bodyweight ranging between
50kg and 80kg were studied. Each animal underwent two
procedures under general anesthesia on separate days
with a 7–10 day recovery period in between. On the first
procedure, laparoscopic liver ablation zoneswere produced
(Medical microwave systems research group, Bangor
University, UK). During the second procedure CLE images
and liver biopsies were obtained. In two animals a left
laparoscopic hemihepatectomy was carried out prior to
imaging, to evaluate CLE examination of the surgical
resection margin.
Preparation and Anesthesia
Following best practice animal husbandry, themini-pigs
were acclimatized to their surroundings with free access to
food and water at least 1 week prior to experiments. To
avoid intestinal distension animals were fasted 24 hours
prior to surgery but had continual access to water. Oral
endotracheal intubation facilitated general anesthesia
with 2% Isoflurane in oxygen in a recovery (ablation) or
nonrecovery (CLE imaging) algorithm with 200mg Pento-
barbitone euthanasia at termination of surgery.Orogastric
intubation decompressed the stomach during laparoscopy.
All procedures were carried out with the animals in a
supine position.
In Vivo Image Acquisition
Following establishment of the pneumoperitoneum,
abdominal contents were visually inspected for potential
ablation induced collateral injuries. All imaging experi-
ments were recorded with the laparoscopic camera and
stored as digital files. Position of the CellvizioTM probe tip
in relation to the ablation zones examined could be
identified on video and correlated with the recorded CLE
images for future analysis. Immediately before liver
imaging, a standardized CellvizioTM system calibration
procedure [21] was carried out in theater. Baseline CLE
images were recorded over normal and ablated liver,
respectively. Fluorescein sodium (molecular weight
376.27 g/mol—henceforth called “fluorescein”) and ICG
(molecular weight 774.96 g/mol) were mixed with 50ml
0.9% sodium chloride or 5% dextrose, respectively, just
prior to intravenous injection. Intravenous injection of
fluorescein (at 4–7mg/kg) and indocyanine green (at 0.3–
0.5mg/kg) was carried out sequentially with an interval of
30–60 minutes between injections. Fluorescein and ICG
acted as fluorophores for CLE imaging at 488nm and
660nm wavelength, respectively. CLE image acquisition
was carried out with separate systems for each individual
wavelength (CellvizioTM 488nm and CellvizioTM 660nm,
Mauna Kea Technologies, Paris). In addition to this
protocol, two animals underwent fluorophore injection 15
minutes prior to ablation therapy to determine if the time
point of injection impacted on CLE imaging character-
istics. In preliminary bench experiments, it was confirmed
that the illumination—emission spectra were so widely
separated, that there was no cross-talk between the 488-
fluorescein and the 660-ICG systems. An initial image
sequence was recorded tomonitor and confirm distribution
of the fluorophores in the liver. This was followed by
several short sequence acquisitions taken in equal
numbers from normal parenchyma and ablated regions.
Short sequences ranged from 10 to 20 seconds and were
later analyzed to determine variations of relative fluores-
cence between healthy and ablated liver tissue.
When visualization became impeded by blood or other
detritus that had attached itself to the tip of the probe, it
was cleaned with normal saline. This reflects the value of
an imaging scheme rather than a single fiber spectrometer.
In the latter case a low signal could represent either a lack
of fluorophore or a fouled fiber tip—enhancing the risk of a
false reading from a given sampling site.
Before experiments commenced, a training session was
conducted to familiarize surgeons with CLE probe han-
dling during laparoscopy. Particular attention was paid to
probe tip pressure because too little pressure resulted in
insufficient tissue contact, whereas too much pressure
severely diminished fluorescence intensity. Both extremes
resulted in the loss of any measurable fluorescence
intensity and hence a black image which again demon-
strates the value of an imaging system rather than a
spectrometer fiber. The training session allowed surgeons
to find a narrow range of tip pressure that enabled image
acquisition at a visibly stable fluorescence level. From a
surgical technique point of view, deliberate adjustment
of pressure within this narrow window was very challeng-
ing, without haptic feedback so no formal quantification
of probe tip pressure was undertaken. None of the image
data acquired during the training session was used for
analysis.
Operative Technique
Pneumoperitoneum was established using either the
Veress technique or port insertion under direct vision. A
periumbilical 10mm port was used for the laparoscopic
camera with additional 5mm and 10mm ports inserted in
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the right and left upper quadrants. For ablation, one
additional 5mm port was inserted in the right subcostal
region. Liver resection was performed using four ports in
addition to the camera port; three in the right upper and
one in the left upper abdomen. Pneumoperitoneum was
constantly monitored andmaintained at 8–12mmHg. The
porcine equivalent of a left hemihepatectomy was carried
out without vascular inflow occlusion. A portable ultra-
sonic scalpel (SonicisionTM, Covidien, Dublin, Ireland) was
used for transection of the liver parenchyma. Small vessels
were controlled with ultrasonic scalpel or metal clips,
whereas major vessels were divided with a laparoscopic
stapling device (Echelon EndopathTM, Ethicon Endo-
Surgery, Blue Ash).
CLE Equipment
Experiments were performed sequentially in a “dual
wave length approach” using both 488nm (blue) and
660nm (red) laser lines which were connected to separate
CLE imaging systems (CellvizioTM 488nm and CellvizioTM
660nm, Mauna Kea Technologies, Paris). For CLE image
acquisition 0.5–1.5mm, flexible confocal probes (MiniZ,
Ultra MiniO and S1500, Mauna Kea Technologies, Paris,
France) were used, all compatible with conventional
endoscopic instrument channels. The CLE imaging sys-
tems control laser illumination and fiber scanning,
delivering 12 frames per second which enables near real-
time image acquisition. Images at different wavelengths
were recorded “in turn,” meaning without parallel cor-
egistration of the red- and blue-light laser systems.
Imaging parameters were probe dependent with 1.4–
3.5mm lateral resolution, 10–30mm axial resolution,
0–70mm imaging depth and a 240–600mm2 fields of view.
The confocal probes were inserted into the peritoneal
cavity through the lumen of a steerable catheter (AgilisTM
St. Jude Medical, Saint Paul, MN) which was itself
introduced through a 5mm laparoscopic port. The steer-
able catheter, designed for intravascular use, allowed
subtle manipulation of the probe tip during laparoscopy
(Fig. 1a). A technical note on this approach to probe
manipulation has been reported elsewhere [22].
Preparation of Tissue Samples
Following termination of the animals, the ablation zones
and the surrounding healthy liver were resected for
histological analysis. During surgery, if more than one
ablation zone was examined, they were assigned numbers
and their anatomical position was recorded during
laparoscopy with the intention to facilitate postoperative
CLE image analysis for each individual lesion. No attempt
was made to perform a more detailed spatial correlation
between CLE- and histopathological images because the
CLE probe’s field of view (<300mm2) was too small to
accurately localize with markings that would have been
visible on laparoscopy.
Samples were fixed in formalin and then embedded in
paraffin. Tissue samples were sliced with a histiotome in a
direction parallel to the liver surface. These slices were
placed on glass slips and stained according to a standard
Haematoxylin & Eosin protocol.
Statistical Analysis
Using an integrated software package (ImageCellTM,
Mauna Kea Technologies, Paris, France) mean fluores-
cence values for each image frame were recorded and
exported for statistical comparison. The values were
termed “relative fluorescence units” (RFU).
Negative RFU values can potentially represent either
image noise, or loss of autofluorescence due to prolonged
illumination causing a “photo-bleach” effect [21]. To avoid
misinterpretation, negative RFU values were therefore
thresholded at zero. Image sequences for each separate
animal/imaging session were divided into two groups:
normal liver parenchyma and ablated liver parenchyma,
depending on the type of liver tissue they were recorded
from. The mean RFU value for each image frame was
compared between these two groups. Because of its
technical design, each recalibration of the CellvizioTM
system influences the RFU value. Data was, therefore,
compared only for the same calibration event and experi-
ment and normal and ablated tissues were only compared
for the same animal. To adjust the data for erratic probe
movement all laparoscopic videos were reviewed. If there
Fig. 1. (a) Laparoscopic CLE imaging of porcine liver with fluorescein/488nm. The ablated regions
are highlighted with dashed circles. (i) Steerable catheter inserted through a laparoscopic port; (ii)
CLE probe with blue light reflex at the tip. (b) Workflow of statistical analysis.
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was a clear disconnection between the probe tip and the
liver surface the relevant data sequencewas excluded from
analysis.
Evaluation of data distribution using the Kolmogorov–
Smirnov test showed that the values in both groups were
nonparametric. There was an unequal number of frame
values in both groups, which would invalidate routine
paired group comparison (e.g., paired Wilcoxon rank sum
test). For this reason data were analyzed employing a
generalized linear mixed model (GLIMMIX) which allows
for the incorporation of fixed (RFU, ablated vs. normal
liver) and random (animal ID) effects. This facilitated
comparison of unequally sized groups and accommodated
changes in theRFUvalueswith each new calibration of the
CellvizioTM.
The GLIMMIX analysis was set up to model the
probability of the probe being on normal (i.e., nonablated)
liver parenchyma. The measured RFU value was set up as
fixed effect and the animal ID (and therefore potential
changes with each new calibration) was set as a random
effect in the model. To reduce data skew and kurtosis,
mean values for each frame were transformed using the
root-square transformation. The GLIMMIX analysis was
based on the estimation of residual marginal expansion
pseudo-likelihood. Glimmix result output is given as the
change in odds ratio for an increase in RFU at a
standardized value. For example, an odds ratio of 2.0 at
standardized value of 100 to 101 RFUmeans that the odds
ratio of liver parenchyma being normal increases by two if
the RFU value increase by one from 100 to 101.
To test the validity of the GLIMMIX model a receiver
operating characteristic (ROC) analysis was performed.
The covariates and intercepts provided by the GLIMMIX
analysis were used to calculate the log odds, odds and
finally the probability of identifying nonablated tissue.
Each single probability value corresponded to a single
observation (mean RFU per frame), a specific animal ID
and a tissue type, which enabled us to perform a ROC
analysis based on this data. Because animal ID was a
random effect, the same RFU value would result in
different probability values for the individual animals.
This relationship explainswhy based on our data, no single
RFU cut-off value can be estimated as an optimal threshold
to distinguish ablated from nonablated tissue.
Statistically significant differences were accepted if
P< 0.05. Statistical analysis was performed using SPSSTM
Version 21 (IBM, Armonk, NY) with exception of the
GLIMMIX analysis which was carried out with SASTM
Version 9.4 (SAS Institute, Cary, NC). Nontransformed
group values are given as median and interquartile range.
The workflow for the statistical analysis is shown in
Figure 1b.
RESULTS
Descriptive Evaluation of Liver Histology
General histology. The histological samples obtained
within 7–10 days of microwave ablation showed different
degrees of cellular injury in the ablated areas. Centrally,
within the ablation zone, tissue appeared macroscopically
white and on histology, showed complete coagulation
necrosis. Surrounding these areas was a rim of tissue
that showed signs of sinusoidal obstruction, cell shrinkage
and disruption of lobular architecture. On macroscopic
inspection these areas were difficult to distinguish from
the normal liver tissue in the periphery, validating the use
of a sensitive imaging instrument for this purpose.
CLE evaluation of fluorescein at 488nm—normal
liver. CLE images are shown adjacent to histology
sections, obtained from normal porcine liver after conclu-
sion of the experiments. To facilitate comparison, CLE
images are shown in parallel to histology slides with
comparable architectural features from the same animal.
When using 488nm CLE, no auto-fluorescence signals
were recordable from the tissue before fluorescein admin-
istration. Intravenous fluorophore injection was followed
by an “inflow phase” where the fluorophore is distributed
and taken up by the liver parenchyma. This phase lasts for
approximately 7–10 minutes after injection and is charac-
terized by bright signals in blood vessels contrasting with
dark lobule areas (Fig. 2a and b). Using CLE imaging of
fluorescein at 488nm, individual erythrocytes flowing
through blood vessels could be observed with greater
regularity than was possible with CLE imaging of ICG at
660nm. Unfortunately, the limited image resolution made
a more detailed analysis of blood vessel flow difficult at
either wavelength.
The inflow phase was followed by the “parenchymal
phase” when the fluorescence pattern is reversed as the
fluorophore has been redistributed from the vasculature
into the liver parenchyma. During this phase, the
vasculature is devoid of fluorescence signal and can
be visualized as dark lines of increased contrast (i.e.,
absence of fluorescence) that surrounds the liver lobules,
which had by then become rich in fluorescein (Fig. 2c and
d). CLE imaging of fluorescein at 488 nm allowed
sinusoid structure and individual hepatocyte cords
visualization (Fig. 2e and f). Usually, a distinction
between different types of vessels (arterial/venous) is
not feasible, but in some instances the location and
morphology of blood vessels can reveal its specific
characteristics (Fig. 2g and h).
CLE of ICG at 660nm—normal liver. Similar to the
fluorescein system, 660nm CLE illumination of ICG,
demonstrated no tissue auto-fluorescence and thus no
imaging of liver architecture was possible prior to
fluorophore administration.
In contrast to CLE of fluorescein under 488nm excita-
tion, it was not possible to visualize any significant
fluorescencewithin the intravascular compartment during
the “inflow phase.” The combination of ICG and 660nm
CLE, however, appeared to be better suited to imaging the
sinusoid structure within liver lobules (Fig. 3a and b).
Because ICG is rapidly taken up and cleared by the
hepatocyte cytoplasm, the hepatocyte nuclei were seen
outlined as dark spots within the liver cells (Fig. 3c and d).
Central lobular veins that drain the blood toward the
hepatic venous system could be seen as round dark
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structures within the center of a lobule (Fig. 3e and f).
Because the vasculature and connective tissues were both
devoid of fluorescence signal in the parenchymal phase,
blood vessels could not be distinguished from interlobular
septations when using ICG as sole fluorophore
(Fig. 3g and h). Within this limitation, the visualization
of fibrous tissue septations between lobules was readily
reproducible with ICG CLE at this wavelength. Between
30 and 40 minutes after ICG infusion, bright spots were
seen appearing throughout the liver parenchyma (Fig. 4a).
This phenomenon possibly represents areas of ICG
accumulation (e.g., bile juice).
Fig. 3. Comparison of CLE imaging with ICG/660nm and H&E liver histology. (a and b) Typical
sinusoidal architecture of normal porcine liver. Sinusoids. (c and d) Hepatocyte nuclei appear as
intracellular contrast sparing. arrows, nuclei. (e and f) The dark central area represents a
centrilobular vein. Note how the vessel lumen appears ragged because ICG does not accumulate in
the vascular endothelial cells. (g and h) Interlobular septations appear as linear contrast sparing
areas between liver lobules. #Septation; liver lobule.
Fig. 2. Comparison of CLE imaging with fluorescein/488nm and H&E liver histology. (a and b)
Strong fluorescence signal in the intravascular compartment during the inflow phase. Liver
lobules; arrows, interlobular vessels. (c andd) Shift of fluorescence signal from the intravascular- to
the intracellular compartment in the parenchymal phase. #Liver lobules; vessel bifurcation;
arrows, vessel branches. (e and f) Pattern of sinusoidal architecture. Horizontal sinusoid;
arrows, perpendicular sinusoid. (g and h) Vessel bifurcation of a centrilobular vein. Vessel lumen;
arrows, vessel branches.
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Probe manipulation, placement, and image qual-
ity.As the CLE probe has no inherent navigability, the use
of an intravascular catheter (AgilisTM St. Jude Medical,
Saint Paul, MN) afforded free rotation, flexion, and
retroflexion to 1808. Familiarity with the steering system
allowed instant successful use of the CLE instrument
without additional prior expertise or training.
This degree of maneuverability allowed access to
virtually any area on the liver surface (Fig. 1a). The
main detractor to image quality was the respiratory
movement of the liver. Thismademethodical and complete
examination of liver tissue difficult because tissue contact
loss would frequently occur with each respiratory cycle.
The problem of respiratory interference to CLE signal was
greater on the anterior and superior surfaces of the liver
and was compounded by pooling of fluids or blood on the
liver surface which increased probe tip slipping. The size of
the steerable access catheter allowed parallel insertion of
two CLE probes, this method however made overall
handling difficult and impaired image quality.
Evaluating ablation zones and liver resection
surface. In ablated liver tissue, the characteristics of
CLE images recorded with fluorescein and ICG were
similar in all the animals studied.Whether the fluorophore
was injected before or after ablation was carried out, did
not affect visualization of tissue characteristics. In the
majority of the ablation zone, no fluorescence was
detectablewhich corresponded to zones of ablation induced
injury on histology (Fig. 5). When examining the border
region between normal and ablated liver, the change from
high to low fluorescence zone could often be observed in the
same field of view (Fig. 6). Because it was technically
difficult to stabilize the probe over a very small area
(<1mm), no differentiation between zones of cellular
apoptosis and necrosis could be made. Similar to zones of
ablated liver, the liver resection surface (divided using the
ultrasonic scalpel) did not show any significant fluores-
cence signals. If signals were recorded on the resection
surface, they usually originated from linear structures of
high signal intensity that potentially represent vessels
(Fig. 4b and c) or zones of fluorophore extravasation
following the destruction of fluorophore containing vessels.
Analysis of fluorescence values.Overall RFU values
measured in nonablated versus ablated tissue decreased
by 75–94% and 77–100% for CLE imaging with the
fluorescein/488nm system and the ICG/660nm system,
respectively (Fig. 7). In Table 1, median RFU values for
each animal and tissue type are shown with ablated tissue
further subdivided into individual lesions.
With CLE of fluorescein using 488nm excitation, a
standardized RFU value change from 41 to 42 (square root)
increased the odds ratio of liver parenchyma being normal
Fig. 4. (a) Bright foci of fluorescence (arrows) at the later stages of CLE imaging with ICG/660nm
may correlate with areas where bile juice accumulates. The surface of the resected liver is mostly
devoid of fluorescence but occasionally band-like fluorescence signals can be seen at 488nm (b) and
660nm (c) wavelength.
Fig. 5. Areas of complete necrosis with fluorescein/488nm (a) and ICG/660nm (b) show loss of
fluorescence intensity which correlates with complete destruction of hepatic architecture on H&E
histological analysis (c).
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(i.e., nonablated) by 1.16 (P< 0.0001; CI 1.15–1.17). At this
fluorophore and wavelength combination the variation
introduced by imaging individual animals and recalibrat-
ing the CellvizioTM system did not contribute to the fit of
the model as a random effect with a covariance parameter
of 1.66 1.66 (SEM, P>0.05). The covariance parameter
estimation indicates to what degree the random variable
affects the fit of the model (i.e., it aids in predicting
outcome) of the model and its associated standard error
gives ameasure of repeat sampling variability. Thismeans
that the same RFU values could be applied across different
animals in the study to predict the presence of healthy liver
tissue. ROC analysis resulted in an area under the curve of
0.9550.003 (P< 0.0001, CI 0.95–0.96).
A standardized RFU value change from 17 to 18 (square
root) with CLE imaging of ICG at 660nm increased the
odds ratio of liver parenchyma being normal by 1.58
(P< 0.0001, CI 1.54–1.63). Variation introduced by individ-
ual animals and recalibrationdid significantly contribute to
the fit of the model as a random effect with a covariance
parameter estimation of 4.63.8 (SEM, P<0.05). This
means that the predictive RFU values were not inter-
changeable for different animals in the study as each
individual’s fluorophore distribution pattern within the
areas of interest, were unique to that animal. ROC analysis
resulted in an area under the curve of 0.999 0 (P< 0.0001,
CI 0.998–1.0).
DISCUSSION
This study has demonstrated that confocal laser
endomicroscopy can be used in vivo to distinguish
thermally ablated liver, from healthy liver, during
laparoscopic surgery. The main discriminating factor
between healthy and ablated tissue was loss of fluores-
cence intensity as expressed by RFU. This phenomenon
was independent from the time point of fluorophore
injection, which means that it is unlikely to be caused by
the destruction of fluorophore carrying vasculature. It is
proposed that the destruction of fluorophore containing
cellular and intercellular structures that occurs during
liver ablation is themost likely explanation for this finding.
Evaluation of ablated liver tissue is of relevance because
similar to surgical excision of malignancy, a complete
ablation margin around a treated lesion is necessary to
optimize patient survival [23]. An important limitation of
thermal ablation is that it is relatively contraindicated
when the tumor is close to vulnerable structures such as
major bile duct and blood vessel structures [24]. Proximity
Fig. 6. The border between complete necrosis (#) and partial cellular injury () can be visualized
with fluorescein/488nm (a) and ICG/660nm (b). The corresponding H&E histological appearance
can be seen in (c).
Fig. 7. (a) Median RFU values95%CI for each animal liver studied with fluorescein/488nm. (b)
Median RFU values95%CI for each animal liver studied with ICG/660nm. The bar for ablated
tissue in animal ID 1 is not visible because the median and 95%CI is zero.
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to large blood vessels also renders ablation less effective
and predictable because of the “heat sink effect” [24].
Although not demonstrated here, CLE probes could be
deployed close to vulnerable structures to detect thermal
injury and allow the progress of ablation to be monitored.
Because the approach evaluated in this article enables
direct visual tissue assessment in small and distinct areas
of liver parenchyma, it may be advantageous compared to
measuring surrogate markers of tissue necrosis such as
temperature.
An analysis based on generalized linear mixed modeling
has indicated that loss of fluorescence intensity can be used
in vivo to identify ablated or nonvital liver tissue. This type
of analysis was chosen over and above a more simplistic
group-wise comparison because of the specific constraints
that the collected data presented. Firstly, we had to
account for comparing two different types of tissues in the
same animal (normal and ablated); secondly, the tissue
types were repeatedly measured to account for the
inconsistency introduced by CLE probe movement and a
small field of view; thirdly, an incongruent number ofmean
RFU values in each group resulted from having a different
number of frames available for analysis. Lastly, the
absolute values of themeasured RFUwere not comparable
between different experimental days because each new
calibration of the CellvizioTM altered the RFU value.
The general linear mixed model analysis allows for all
these considerations and takes into account the correlation
in measurements between different tissues in the same
animal. It is also able to handle nonparametrically
distributed data. A separate ROC analysis has been used
to confirm the validity of the model. Before fluorescence
values can be used to inform clinical decision making,
however, it is imperative that standardized, absolute
fluorescence values are established. If an ablation depen-
dent variability in absolute fluorescence can be validated
in more extensive datasets, it has the potential to be
transformed into a computational image recognition
algorithm. This algorithm could then be integrated into
a clinical imaging system with the ability to monitor and
map liver ablation.
Each frame value was treated separately because
unavoidable probe movement meant that some sections
of tissue may just be represented by a single frame.
Although a single image frame may not provide enough
data for clinicians to evaluate tissue, it could provide
sufficient data for an automatic tissue evaluation algo-
rithm based on fluorescence intensity.
A description has been provided comparing key charac-
teristics of liver tissue architecture as imaged on fluores-
cein and ICG facilitated CLE examination at 488nm and
660nm wavelength. To account for temporal variations in
imaging characteristics following fluorophore injection, a
categorization into hepatic “inflow” and “parenchymal”
phases has been proposed here. The inflow phase lasts
approximately 7–10 minutes and takes place while the
fluorophore is mainly concentrated in the hepatic vascu-
lature. This blends over into the parenchymal phase when
the bulk of fluorophore concentration has been redistrib-
uted into the intracellular compartment. Although a
TABLE 1. Median RFUValues for Nonablated and Ablated Tissue asWell as for Each Individual Lesion ThatWas
Examined During Experiments
Animal ID. Type of tissue Fluorescein and 488nm ICG and 660nm
1 Nonablated  514 (624)
Ablated  0 (20)
RFU change in % 100%
Lesion 1  20 (18)
Lesion 2  0 (0)
2 Nonablated 3,030 (1,868) 893 (240)
Ablated (Lesion 1) 169 (862) 210 (123)
RFU change in % 94% 77%
3 Nonablated 5,978 (3,782) 570 (254)
Ablated 1,177 (949) 37 (29)
RFU change in % 80% 94%
Lesion 1 1,177 (949) 17 (8)
Lesion 2  63 (106)
Lesion 3  36 (2)
4 Nonablated 1,778 (846) 1,221 (532)
Ablated 443 (627) 27 (3)
RFU change in % 75% 98%
Lesion 1 838 (871) 24 (3)
Lesion 2 381 (192) 20 (16)
Lesion 3 953 (707) 27 (1)
The interquartile range is given in brackets. RFU change states the decrease of median RFU values in nonablated (set as 100%) vs.
ablated tissue. No image acquisition for these lesion due to technical issues.
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number of articles have evaluated CLE of the liver for
different indications in animals and humans, [14,15,19,25]
no report to date has made a comparative description by
employing a dual wavelength approach. Because fluores-
cein and indocyanine green have different distribution
properties in tissues [18,26,27], they could be employed
sequentially and within a time frame to allow examination
of a particular area of interest. Overview images obtained
during the inflow phase had different characteristics for
both fluorophore and wavelength combinations. When
focusing on blood flow evaluation in this phase, CLE
examination of fluorescein with the blue-light system was
advantageous because it enabled regular visualization of
erythrocyte movement within sinusoids and larger paren-
chymal vessels. Although ICG is similarly distributed
through the vasculature, it was not possible to detect
intravascular ICG mediated fluorescence in this study. A
group investigating near-infrared CLE imaging of ICG in
patients with liver disease were able to visualize blood flow
in 8 out of 21 patients [18] possibly reflecting low/slow
function of the hepatocytes in these particular eight cases.
No ICG related fluorescence was visualized within
sinusoidal vessels which was also the case in our experi-
ments. It is not possible to draw any conclusions from this
because the employed CLE systems have different
specifications and with only four subjects in our study,
the inability to visualize hepatic blood flow may have been
accidental but it is tempting to ascribe it to good hepatocyte
affinity for ICG in health, allowing a one-pass clearance
effect.
In the parenchymal phase, CLE of the fluorescein/
488nm system was better suited to imaging blood vessel
morphology because low contrast areas correlated better
with blood vessels, whereas these areas in the ICG/660nm
system were consistent with both fibrous tissue septations
and vasculature. A more homogenous and intense distri-
bution of fluorescence throughout the liver tissue indicated
that fluorescein accumulated in hepatocytes and other
cells (e.g., fibrocytes and vascular endothelial cells). In
comparison, ICG CLE at 660nm revealed a high affinity of
ICG to hepatocytes with nuclear sparing, providing a
strong contrast. Visualization of interlobular septation
architecture appeared to be better suited to the 660nm
CLE system with ICG, which was able to clearly delineate
liver lobules from surrounding fibrous tissue. At 30–40
minutes after ICG injection areas of 5–20mm2 could be
observed that accumulated high fluorescence intensity.
Given that ICG is known to be rapidly excreted via
bile [26], it is proposed that these signals may represent
bile canaliculi, the smallest division of bile ducts . The
fluorophore choice of fluorescein and ICG was guided by
potential clinical applicability. There are many other
potential fluorophores for 488–660nm CLE, but none are
currently approved for clinical use or have the same low
risk profile as fluorescein and ICG [26,27]. The latter two
fluorophores have been used in CLE studies of the human
liver in the past [18,19] which could aid in the transfer-
ability of our findings to a clinical evaluation of CLE
imaging in liver ablation.
Overall, the detection sensitivity of ICG fluorescence
intensity at 660nm was lower when compared to fluores-
cein at 488nm wavelength. This was likely due to the fact
that the optical absorption maximum of ICG is 800nm
(near-infrared spectrum) so our excitation efficiency was
poorer at 660nm, and while not optimal, was adequately
within the excitation range to excite fluorescence emis-
sions for this fluorophore. This illumination wavelength is
a manufacturer preset and cannot be altered. Near-
infrared CLE imaging, however, is not available yet in a
CE marked system and we felt that adequate signal was
achieved in the system described, as the fluorophore has
attractive properties relevant for clinical liver and bile duct
imaging [26].
Although porcine models are frequently used to
evaluate novel surgical technologies [28,29], the result-
ing findings have to be interpreted with caution. Firstly,
porcine liver histology differs from humans with more
pronounced interlobular septations. Despite these differ-
ences, authors with extensive experience in CLE imaging
of the liver state that data acquired from animal studies
can be regarded as equivalent to human data [12].
Secondly, we found during laparoscopy that the pig’s
distinctive multilobulated liver configuration altered the
handling and manipulation of the liver considerably in
comparison with the expected characteristics in humans.
Although the number of animals tested was small, the
extensive data acquisition was comparable to similar
studies published by other groups [14,30]. The acquired
number of images was sufficient to describe dual
wavelength CLE imaging features and to evidence the
feasibility of using fluorescence values to distinguish
between vital and ablated liver parenchyma in an
individual. Establishing large animal models of liver
malignancy is expensive, time consuming, and not
routinely employed for research purposes [31]. Therefore,
the pig model employed in this article solely focused on
assessment of ablated tissue and did not account for the
presence of malignant tissue with its commonly associ-
ated vascular disturbances, as would be encountered
during clinical liver ablation procedures. The advantage
of CLE imaging compared to a simpler fluorescence
detection device is that it has the ability to demonstrate
tissue architecture and thus discriminate between
malignant and benign tissue [13], but due to the
limitations of the porcine model this aspect could not
be evaluated in this study. In addition, the image quality
alludes to fouling of the tip—a danger in single fiber
spectrophotometry systems reporting no signal due to
absence of fluorophore or a fouled tip?
The relation and distribution of fluorescence character-
istics in healthy and ablated liver tissue demonstrated in
this article indicate that CLE may well have utility in
ablation monitoring but further research is required.
Before absolute RFU values can be compared between
different experiments or between research groups, the
CellvizioTM platform or alternative CLE imaging systems
would need to be adjusted and standardized to allow
reproducible calibration of fluorescence intensity.
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At this stage, CLE imaging can offer micron level
resolution in discriminating ablated from nonablated liver
tissue andmay, therefore, be of interest as a novel imaging
tool in liver ablation research. If clinical translation is
considered in the future, technical limitations imposed by
CLE imaging depth and probe vulnerability will have to be
addressed.
The feasibility of utilizing needle based, diffuse optical
spectroscopy to evaluate liver malignancy [32,33] and
steatosis [34] has been demonstrated in the past. A similar
needle-based approach could also be applied to increase the
imaging depth of CLE, which is currently restricted to
<200mm. The smallest commercially available CLE probe
has a diameter of 300mm, which would enable insertion
through the bore of a 24G needle which is smaller than
liver core biopsy needles currently in routine use and,
therefore, less likely to cause inadvertent injuries. Once
placed within the bore of the needle, the CLE probe could
be inserted into the liver parenchym under USS guidance.
Correlation of USS and CLE images could then, respec-
tively, provide anatomical and functional information
about the adequacy of ablation therapy.
In the diagnosis and treatment of abdominal malig-
nancy, there are a number of scenarios (e.g., transgastric
fine needle aspiration of the pancreas, irreversible
electroporation of the pancreas, liver biopsy) where a
needle is intentionally inserted intomalignant tissue. This
is feasible because the risk of needle tract seeding is either
small or outweighed by the clinical benefits of the
procedure [35–37]. To minimize the risk of needle tract
seeding from needle-based CLE, an ablation of the needle
tract should be carried out which is advocated by some
authors as routine practice in any laparoscopic liver
ablation [3]. In addition, if the procedure is being
conducted anyway, the obtaining of CLE data through
the same needle track simply adds to the benefits side of
the risk evaluation and offers the possibility of increased
data yield from the same clinical exercise. Further testing
and validation in an experimental setting will be required
to elucidate if this solution is feasible. Until feasibility has
been confirmed, experimental CLE ablation monitoring
should be restricted to superficial liver tumors that do not
require a needle based approach.
Another technical issue is the CLE probe’s vulnerability
to high temperatures. The CellvizioTM probes are only
licensed to work within the range of normal body
temperature whereas liver ablation may generate temper-
atures in excess of 1008C. This may prevent real time CLE
monitoring within the center of an ablation zone but the
temperature in the periphery of an ablated region is
generally lower than in the center and rapidly deterio-
rates [38]. Temperatures that are within the working
range of a CLE probe can be expected within minutes of
completing liver ablation therefore potentially allowing
assessment during the same treatment session as near-
real time monitoring.
In summary, this article has assessed dual-wavelength
CLE for evaluating ablation therapy of focal liver lesions
under laparoscopic guidance. Intraoperative CLE image
acquisition during liver resection has been shown to be
technically possible. In addition to a descriptive evalua-
tion it was demonstrated that numerical analysis of
fluorescence intensity could be employed to confirm the
extent of liver ablation. Based on our findings, CLE may
be of interest as a novel imaging modality in liver
ablation research. Further investigation seems war-
ranted to examine if technical limitations, that currently
prevent a clinical translation of this approach, can be
overcome.
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